California sought to enjoin Defendant DaVita from acquiring Defendant Gambro because it was alleged that the merger would substantially reduce competition for the provision of renal dialysis services and create a monopoly. Defendants agreed to the entry of a consent decree and judgment which provided that defendants could merge after they divested 35 clinics. Further, for 5 years the parties were enjoined from acquiring any asset of, financial interest in, management of, or operation of any clinic in certain delineated geographic areas without giving the State 30 days prior written notice. The consent decree also mandated the appointment of a Monitor to assure that DaVita expeditiously complies with the terms of the consent decree. DaVita was ordered to pay fees and costs in the amount of $85,000. The Federal Trade Commission participated in this investigation.